Accelerate Diagnostics Statistics
Share Statistics
Accelerate Diagnostics has 25.29M
shares outstanding. The number of shares has increased by 14.33%
in one year.
Shares Outstanding | 25.29M |
Shares Change (YoY) | 14.33% |
Shares Change (QoQ) | 0.67% |
Owned by Institutions (%) | 1.31% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 120 |
FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 297.38K, so 1.19% of the outstanding
shares have been sold short.
Short Interest | 297.38K |
Short % of Shares Out | 1.19% |
Short % of Float | 1.76% |
Short Ratio (days to cover) | 14.17 |
Valuation Ratios
The PE ratio is -0.56 and the forward
PE ratio is -0.09.
Accelerate Diagnostics's PEG ratio is
0.01.
PE Ratio | -0.56 |
Forward PE | -0.09 |
PS Ratio | 2.39 |
Forward PS | 0 |
PB Ratio | -0.5 |
P/FCF Ratio | -1.13 |
PEG Ratio | 0.01 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Accelerate Diagnostics.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.71,
with a Debt / Equity ratio of -1.19.
Current Ratio | 0.71 |
Quick Ratio | 0.62 |
Debt / Equity | -1.19 |
Debt / EBITDA | -1.98 |
Debt / FCF | -2.7 |
Interest Coverage | -2.69 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $109,327.1 |
Profits Per Employee | $-467,710.28 |
Employee Count | 107 |
Asset Turnover | 0.41 |
Inventory Turnover | 3.15 |
Taxes
Income Tax | -66K |
Effective Tax Rate | 0.13% |
Stock Price Statistics
The stock price has increased by -97.64% in the
last 52 weeks. The beta is 0.22, so Accelerate Diagnostics's
price volatility has been higher than the market average.
Beta | 0.22 |
52-Week Price Change | -97.64% |
50-Day Moving Average | 0.64 |
200-Day Moving Average | 1.29 |
Relative Strength Index (RSI) | 12.62 |
Average Volume (20 Days) | 1,856,939 |
Income Statement
In the last 12 months, Accelerate Diagnostics had revenue of 11.7M
and earned -50.05M
in profits. Earnings per share was -2.15.
Revenue | 11.7M |
Gross Profit | 2.7M |
Operating Income | -35.31M |
Net Income | -50.05M |
EBITDA | -33.57M |
EBIT | -36.99M |
Earnings Per Share (EPS) | -2.15 |
Full Income Statement Balance Sheet
The company has 15.1M in cash and 66.58M in
debt, giving a net cash position of -51.48M.
Cash & Cash Equivalents | 15.1M |
Total Debt | 66.58M |
Net Cash | -51.48M |
Retained Earnings | n/a |
Total Assets | 28.56M |
Working Capital | -8.96M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -24.19M
and capital expenditures 0, giving a free cash flow of -24.7M.
Operating Cash Flow | -24.19M |
Capital Expenditures | n/a |
Free Cash Flow | -24.7M |
FCF Per Share | -1.06 |
Full Cash Flow Statement Margins
Gross margin is 23.12%, with operating and profit margins of -301.85% and -427.81%.
Gross Margin | 23.12% |
Operating Margin | -301.85% |
Pretax Margin | -428.37% |
Profit Margin | -427.81% |
EBITDA Margin | -287% |
EBIT Margin | -301.85% |
FCF Margin | -211.17% |